Your browser doesn't support javascript.
loading
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China.
Chen, Shaomin; Ying, Zhifang; Liu, Yan; Li, Yuan; Yu, Yebin; Huang, Meilian; Huang, Zhuhang; Ou, Zhiqiang; Liao, Yuyi; Zhang, Yong; Liu, Guixiu; Zhao, Weiwei; Fu, Rong; Shou, Qiong; Zheng, Minghuan; Liao, Xueyan; Tu, Yingmei; Stek, Jon; Hartzel, Jonathan; Li, Changgui; Zhang, Jikai.
Afiliação
  • Chen S; Biological Products Surveillance and Evaluation, Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong, China.
  • Ying Z; Respiratory Virus Vaccine, National Institutes for Food and Drug Control, Beijing, China.
  • Liu Y; Division of Hepatitis Virus and Enterovirus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
  • Li Y; Biological Products Surveillance and Evaluation, Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong, China.
  • Yu Y; Vaccine Clinical Research Office, Yangchun Center for Disease Control and Prevention, Yangchun, Guangdong, China.
  • Huang M; Vaccine Clinical Research Office, Yangchun Center for Disease Control and Prevention, Yangchun, Guangdong, China.
  • Huang Z; Biological Products Surveillance and Evaluation, Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong, China.
  • Ou Z; Biological Products Surveillance and Evaluation, Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong, China.
  • Liao Y; Biological Products Surveillance and Evaluation, Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong, China.
  • Zhang Y; Division of Hepatitis Virus and Enterovirus Vaccines, National Institutes for Food and Drug Control, Beijing, China.
  • Liu G; Clinical Research, MSD Research and Development (China) Co. Ltd., Beijing, China.
  • Zhao W; Biostatistics and Research Decision Sciences, MSD Research and Development (China) Co. Ltd., Beijing, China.
  • Fu R; Biostatistics and Research Decision Sciences, MSD Research and Development (China) Co. Ltd., Beijing, China.
  • Shou Q; Biostatistics and Research Decision Sciences, MSD Research and Development (China) Co. Ltd., Beijing, China.
  • Zheng M; Clinical Research, MSD Research and Development (China) Co. Ltd., Beijing, China.
  • Liao X; Clinical Research, MSD Research and Development (China) Co. Ltd., Beijing, China.
  • Tu Y; Infectious Diseases/Vaccines Clinical Research, Merck & Co. Inc., Rahway, NJ, USA.
  • Stek J; Infectious Diseases/Vaccines Clinical Research, Merck & Co. Inc., Rahway, NJ, USA.
  • Hartzel J; Biostatistics and Research Decision Sciences, Merck & Co. Inc., Rahway, NJ, USA.
  • Li C; Institute for Control of Biological Products, National Institutes for Food and Drug Control, Beijing, China.
  • Zhang J; Directors Office, Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong, China.
Hum Vaccin Immunother ; 20(1): 2324538, 2024 Dec 31.
Article em En | MEDLINE | ID: mdl-38509699
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poliomielite / Vacinas contra Rotavirus / Poliovirus Limite: Humans / Infant País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poliomielite / Vacinas contra Rotavirus / Poliovirus Limite: Humans / Infant País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article